These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 36268184)

  • 21. Cardiovascular Manifestations of COVID-19 Infection.
    Magadum A; Kishore R
    Cells; 2020 Nov; 9(11):. PubMed ID: 33228225
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comorbidities and Symptomatology of SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus 2)-Related Myocarditis and SARS-CoV-2 Vaccine-Related Myocarditis: A Review.
    Cushion S; Arboleda V; Hasanain Y; Demory Beckler M; Hardigan P; Kesselman MM
    Cureus; 2022 Apr; 14(4):e24084. PubMed ID: 35573496
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Incidence, risk factors, natural history, and hypothesised mechanisms of myocarditis and pericarditis following covid-19 vaccination: living evidence syntheses and review.
    Pillay J; Gaudet L; Wingert A; Bialy L; Mackie AS; Paterson DI; Hartling L
    BMJ; 2022 Jul; 378():e069445. PubMed ID: 35830976
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunological response and temporal associations in myocarditis after COVID-19 vaccination using cardiac magnetic resonance imaging: An amplified T-cell response at the heart of it?
    Vago H; Szabo L; Szabo Z; Ulakcsai Z; Szogi E; Budai G; Toth A; Juhasz V; Dohy Z; Hoffer K; Becker D; Kiss RG; Nagy GG; Nagy G; Merkely B
    Front Cardiovasc Med; 2022; 9():961031. PubMed ID: 36186968
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Host Response to SARS-CoV2 and Emerging Variants in Pre-Existing Liver and Gastrointestinal Diseases.
    Nayak B; Lal G; Kumar S; Das CJ; Saraya A; Shalimar
    Front Cell Infect Microbiol; 2021; 11():753249. PubMed ID: 34760721
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Temporal relationship of myocarditis and pericarditis following COVID-19 vaccination: A pragmatic approach.
    Anastassopoulou C; Hatziantoniou S; Vlachopoulos C; Spanakis N; Tsioufis C; Tsakris A; Lazaros G
    Int J Cardiol; 2022 Jul; 358():136-139. PubMed ID: 35436559
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Strategies for Targeting SARS CoV-2: Small Molecule Inhibitors-The Current Status.
    Beeraka NM; Sadhu SP; Madhunapantula SV; Rao Pragada R; Svistunov AA; Nikolenko VN; Mikhaleva LM; Aliev G
    Front Immunol; 2020; 11():552925. PubMed ID: 33072093
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Persistent SARS-CoV-2 infection in patients with secondary antibody deficiency: successful clearance following combination casirivimab and imdevimab (REGN-COV2) monoclonal antibody therapy.
    Taha Y; Wardle H; Evans AB; Hunter ER; Marr H; Osborne W; Bashton M; Smith D; Burton-Fanning S; Schmid ML; Duncan CJA
    Ann Clin Microbiol Antimicrob; 2021 Dec; 20(1):85. PubMed ID: 34969393
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term effect of SARS-CoV-2 infection on cardiovascular outcomes and all-cause mortality.
    Aleksova A; Fluca AL; Gagno G; Pierri A; Padoan L; Derin A; Moretti R; Noveska EA; Azzalini E; D'Errico S; Beltrami AP; Zumla A; Ippolito G; Sinagra G; Janjusevic M
    Life Sci; 2022 Dec; 310():121018. PubMed ID: 36183780
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Implications of COVID-19 Vaccination on Hospital Encounters and Outcomes.
    Case BC; Rosenfeld B; Shea C; Rappaport H; Zhang C; Medranda GA; Satler LF; Ben-Dor I; Hashim H; Rogers T; Waksman R
    Am J Cardiol; 2022 May; 170():105-111. PubMed ID: 35227503
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Catecholamines Are the Key Trigger of COVID-19 mRNA Vaccine-Induced Myocarditis: A Compelling Hypothesis Supported by Epidemiological, Anatomopathological, Molecular, and Physiological Findings.
    Cadegiani FA
    Cureus; 2022 Aug; 14(8):e27883. PubMed ID: 35971401
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinically Suspected Myocarditis in the Course of Severe Acute Respiratory Syndrome Novel Coronavirus-2 Infection: Fact or Fiction?
    Ozieranski K; Tyminska A; Jonik S; Marcolongo R; Baritussio A; Grabowski M; Filipiak KJ; Opolski G; Caforio ALP
    J Card Fail; 2021 Jan; 27(1):92-96. PubMed ID: 33166657
    [TBL] [Abstract][Full Text] [Related]  

  • 33. mRNA vaccine-induced T cells respond identically to SARS-CoV-2 variants of concern but differ in longevity and homing properties depending on prior infection status.
    Neidleman J; Luo X; McGregor M; Xie G; Murray V; Greene WC; Lee SA; Roan NR
    Elife; 2021 Oct; 10():. PubMed ID: 34636722
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cardiac MRI Findings of Myocarditis After COVID-19 mRNA Vaccination in Adolescents.
    Chelala L; Jeudy J; Hossain R; Rosenthal G; Pietris N; White CS
    AJR Am J Roentgenol; 2022 Apr; 218(4):651-657. PubMed ID: 34704459
    [No Abstract]   [Full Text] [Related]  

  • 35. Case Series of Potential Cardiac Inflammation Associated With Various SARS-CoV-2 Vaccinations Assessed by Cardiac MRI.
    Jahnke C; Doeblin P; Tanacli R; Witt U; Schneider M; Stehning C; Pieske B; Kelle S
    Front Cardiovasc Med; 2022; 9():829392. PubMed ID: 35463791
    [TBL] [Abstract][Full Text] [Related]  

  • 36. SARS-CoV-2 Infects Human Engineered Heart Tissues and Models COVID-19 Myocarditis.
    Bailey AL; Dmytrenko O; Greenberg L; Bredemeyer AL; Ma P; Liu J; Penna V; Lai L; Winkler ES; Sviben S; Brooks E; Nair AP; Heck KA; Rali AS; Simpson L; Saririan M; Hobohm D; Stump WT; Fitzpatrick JA; Xie X; Shi PY; Hinson JT; Gi WT; Schmidt C; Leuschner F; Lin CY; Diamond MS; Greenberg MJ; Lavine KJ
    bioRxiv; 2020 Nov; ():. PubMed ID: 33173875
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cardiovascular involvement in COVID-19: not to be missed.
    Rocco IS; Gomes WJ; Viceconte M; Bolzan DW; Moreira RSL; Arena R; Guizilini S
    Braz J Cardiovasc Surg; 2020 Aug; 35(4):530-538. PubMed ID: 32864934
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Heart failure secondary to myocarditis after SARS-CoV-2 reinfection: a case report.
    Riedel PG; Sakai VF; Toniasso SCC; Brum MCB; Fernandes FS; Pereira RM; Baldin CP; Baldin CC; Takahasi AY; Shiki H; Krepsky AMR; Macedo DT; Merlo ÁRC; Rohde LEP; Joveleviths D
    Int J Infect Dis; 2021 Dec; 113():175-177. PubMed ID: 34688947
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Innate immunity during SARS-CoV-2: evasion strategies and activation trigger hypoxia and vascular damage.
    Amor S; Fernández Blanco L; Baker D
    Clin Exp Immunol; 2020 Nov; 202(2):193-209. PubMed ID: 32978971
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Science Underlying COVID-19: Implications for the Cardiovascular System.
    Liu PP; Blet A; Smyth D; Li H
    Circulation; 2020 Jul; 142(1):68-78. PubMed ID: 32293910
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.